Reuters logo
BRIEF-Cosmo Pharmaceuticals says ‍FDA accepts new drug application submission for methylene blue mmx​
October 5, 2017 / 5:04 AM / 2 months ago

BRIEF-Cosmo Pharmaceuticals says ‍FDA accepts new drug application submission for methylene blue mmx​

Oct 5 (Reuters) - COSMO PHARMACEUTICALS NV:

* ‍FDA ACCEPTS NEW DRUG APPLICATION SUBMISSION FOR COSMO PHARMACEUTICAL‘S METHYLENE BLUE MMX(TM)​

* ‍FDA SETS PDUFA DATE FOR MAY 21, 2018​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below